Effect of medical therapy on glaucoma filtration surgery rates in Ontario

Archives of Ophthalmology

Volumn 124, Issue 10, 2006, Pages 1472-1477

  Rachmiel, Rony ^a,c   Trope, Graham E ^a   Chipman, Mary L ^a,b   Gouws, Pieter ^a   Buys, Yvonne M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIMATOPROST; BRIMONIDINE; BRIMONIDINE PLUS TIMOLOL; CARBONATE DEHYDRATASE INHIBITOR; COMBIGAN; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; LATANOPROST PLUS TIMOLOL; LATANOPROST PLUS TIMOLOL MALEATE; PROSTAGLANDIN DERIVATIVE; TIMOLOL MALEATE; TRAVOPROST; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANADA; CONFIDENCE INTERVAL; CONTROLLED STUDY; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MEDICAL RESEARCH; OPEN ANGLE GLAUCOMA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; TRABECULECTOMY;

ANTIHYPERTENSIVE AGENTS; DRUG UTILIZATION; GLAUCOMA, OPEN-ANGLE; HUMANS; ONTARIO; OPHTHALMOLOGY; OPTOMETRY; PRESCRIPTIONS, DRUG; PREVALENCE; TRABECULECTOMY;

EID: 33749575852     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.10.1472     Document Type: Article

References (25)

1. Watson PG, Grierson I. The place of trabeculectomy in the treatment of glaucoma. Ophthalmology. 1981;88:175-196.
2. Bateman DN, Clark R, Azuara-Blanco A, Bain M, Forrest J. The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Br J Ophthalmol. 2002;86:551-554.
3. Bateman DN, Clark R, Azuara-Blanco A, Bain M, Forrest J. The impact of new drugs on management of glaucoma in Scotland: observational study. BMJ. 2001;323:1401-1402.
4. Paikal D, Yu F, Coleman AL. Trends in glaucoma surgery incidence and reimbursement for physician services in the Medicare population from 1995 to 1998. Ophthalmology. 2002;109:1372-1376.
5. Walland MJ. Glaucoma treatment in Australia: changing patterns of therapy 1994-2003. Clin Experiment Ophthalmol. 2004;32:590-596.
6. Statistics Canada. Annual demographic statistics: population estimates by age and sex, Canada, provinces and territories, 2001-2003 (including all components of demographic growth). http://www.library.utoronto.ca/datalib/datar/ cstdsp/91-213-xpb/2003/provter/as/inter/as0103.xls. Accessed July 24, 2005.
7. Tuck MW, Crick RP. The projected increase in glaucoma due to an ageing population. Ophthalmic Physiol Opt. 2003;23:175-179.
8. Tuck MW, Crick RP. The age distribution of primary open angle glaucoma. Ophthalmic Epidemiol. 1998;5:173-183.
9. Minassian DC, Reidy A, Coffey M, Minassian A. Utility of predictive equations for estimating the prevalence and incidence of primary open angle glaucoma in the UK. Br J Ophthalmol. 2000;84:1159-1161.
10. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study: prevalence of open angle glaucoma. Arch Ophthalmol. 1994;112:821-829.
11. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266:369-374.
12. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma: the Beaver Dam Eye Study. Ophthalmology. 1992;99:1499-1504.
13. Mitchell P, Smith W, Attebo K, Healy P. Prevalence of open-angle glaucoma in Australia. Ophthalmology. 1996;103:1661-1669.
14. Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a population-based study in the Netherlands: the Rotterdam Study. Ophthalmology. 1994;101:1851-1855.
15. Coffey M, Reidy A, Wormald R, Xian WX, Wright L, Courtney P. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol. 1993;77:17-21.
16. Giuffre G, Giammanco R, Dardanoni G, Ponte F. Prevalence of glaucoma and distribution of intraocular pressure in a population: the Casteldaccia Eye Study. Acta Ophthalmol Scand. 1995;73:222-225.
17. Bonomi L, Marchini G, Marraffa M, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population: the Egna-Neumarkt Study Ophthalmology. 1998;105:209-215.
18. Weih LM, Nanjan M, McCarty CA, Taylor HR. Prevalence and predictors of open-angle glaucoma: results from the Visual Impairment Project. Ophthalmology. 2001;108:1966-1972.
19. Reidy A, Minassian DC, Vafidis G, et al. Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study. BMJ. 1998;316:1643-1646.
20. Baudouin C, Rouland JF, Le Pen C. Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France. Eur J Ophthalmol. 2003;13(suppl 4):S53-S60.
21. van der Valk R, Schouten JS, Webers CA, et al. The impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeries. J Glaucoma. 2005;14:239-242.
22. Whittaker KW, Gillow JT, Cunliffe IA. Is the role of trabeculectomy in glaucoma management changing? Eye. 2001;15:449-452.
23. Strutton DR, Walt JG. Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma. 2004;13:221-226.
24. Rachmiel R, Chipman M, Gouws P, Trope G, Buys Y. Effect of medical therapy on glaucoma filtration surgery rates in Ontario. Poster presented at: Association for Research in Vision and Ophthalmology; May 1-5, 2005; Fort Lauderdale, Fla. Poster 3654/B12.
25. Statistics Canada. Annual demographic statistics: population estimates by age and sex, Canada, provinces and territories, 1971-2001 (including all components of demographic growth). http://www.library.utoronto.ca/datalib/datar/ cstdsp/91-213-pb/2003/provter/as/inter/as7101.xls. Accessed July 24, 2005.